Boulder-based biotech firm raises $620,000 in debt offering

BOULDER — MBio Diagnostics Inc., a Boulder-based biotech company that does rapid on-site sample testing, has raised $620,000 in capital.

MBio is raising funds through a debt offering and option to acquire other securities, according to a Form D filed with the U.S. Securities and Exchange Commission on May 21. The date of first sale was in December last year. MBio did not respond to a request for more information.

MBio is looking to provide rapid testing with technology that goes beyond the traditional paper test (such as what at-home pregnancy tests do today), according to the company’s website. The company has created its “lightdeck technology,” which uses fluorescence illumination and imaging for its tests.



Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>